Paydirt
TC
Insider

Thomas Catinazzo

Chief Financial Officer

Thomas Catinazzo (Chief Financial Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $3.2M of RLAY (187,163 sh across 4 lots, as filed), executed Jun 22.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.1M
shares × price, as filed
Last traded
Sep 8
Filed Sep 9

Median ADV $74.0M across their filed names

Open performance
Volume by month
$3.2M$1.6M$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $156KOct 2025 · sells $158KJan 2026 · sells $105KMar 2026 · sells $178KApr 2026 · sells $230KMay 2026 · sells $228KJun 2026 · sells $3.2MJul 2026 · sells $331KAug 2026 · sells $350KSep 2026 · sells $336K
Buys $0 Sells $5.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names
RLAY Relay Therapeutics, Inc. RLAY · 0 buys · 10 sells 10 filings
Recent filings
RLAYSALE Relay Therapeutics, Inc. View filing → $158K
21,664 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET
RLAYSALE Relay Therapeutics, Inc. View filing → $156K
33,753 sh × $4.63
Exec Jan 28 2025
Filed Jan 30 2025 · 5:30 PM ET